130
Views
46
CrossRef citations to date
0
Altmetric
Original Research

Alteration of melatonin secretion in patients with type 2 diabetes and proliferative diabetic retinopathy

, &
Pages 655-660 | Published online: 19 May 2011

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (5)

Jie Gao, Liming Tao & Zhengxuan Jiang. (2023) Alleviate oxidative stress in diabetic retinopathy: antioxidant therapeutic strategies. Redox Report 28:1.
Read now
Hui Zhu, Zhi-jia Zhao, Hong-yi Liu, Jie Cai, Qin-kang Lu, Lin-dan Ji & Jin Xu. (2023) The melatonin receptor 1B gene links circadian rhythms and type 2 diabetes mellitus: an evolutionary story. Annals of Medicine 55:1, pages 1262-1286.
Read now
Ashay D. Bhatwadekar & Varun Rameswara. (2020) Circadian rhythms in diabetic retinopathy: an overview of pathogenesis and investigational drugs. Expert Opinion on Investigational Drugs 29:12, pages 1431-1442.
Read now
Sirimon Reutrakul, Nantaporn Siwasaranond, Hataikarn Nimitphong, Sunee Saetung, Naricha Chirakalwasan, La-or Chailurkit, Kriangsuk Srijaruskul, Boonsong Ongphiphadhanakul & Ammarin Thakkinstian. (2017) Associations between nocturnal urinary 6-sulfatoxymelatonin, obstructive sleep apnea severity and glycemic control in type 2 diabetes. Chronobiology International 34:3, pages 382-392.
Read now
Almudena Crooke, Fernando Huete-Toral, Alejandro Martínez-Águila, Basilio Colligris & Jesus Pintor. (2012) Ocular disorders and the utility of animal models in the discovery of melatoninergic drugs with therapeutic potential. Expert Opinion on Drug Discovery 7:10, pages 989-1001.
Read now

Articles from other publishers (41)

A. Böhm, V. Lauko, K. Dostalova, I. Balanova, I. Varga, B. Bezak, N. Jajcay, R. Moravcik, L. Lazurova, P. Slezak, V. Mojto, M. Kollarova, K. Petrikova, K. Danova & M. Zeman. (2023) In-vitro antiplatelet effect of melatonin in healthy individuals and patients with type 2 diabetes mellitus. Journal of Endocrinological Investigation.
Crossref
Getasew Alemu Mersha, Destaye Shiferaw Alemu, Meneberesibhat Getie Ferede, Melkamu Temeselew Tegegn, Mikias Mered Tilahun, Merkineh Markos Lorato, Biruk Lelisa Eticha & Asamere Tsegaw Woredekal. (2023) Association of Poor Quality of Sleep with Vision-Threatening Diabetic Retinopathy: A Matched Case–Control Study. Ophthalmology and Therapy 12:2, pages 1141-1153.
Crossref
Roma Patel, Nishant Parmar, Sayantani Pramanik Palit, Nirali Rathwa, A.V. Ramachandran & Rasheedunnisa Begum. (2022) Diabetes mellitus and melatonin: Where are we?. Biochimie 202, pages 2-14.
Crossref
Agostino Milluzzo, Martina Barchitta, Andrea Maugeri, Roberta Magnano San Lio, Giuliana Favara, Maria Grazia Mazzone, Laura Sciacca & Antonella Agodi. (2022) Do Nutrients and Nutraceuticals Play a Role in Diabetic Retinopathy? A Systematic Review. Nutrients 14:20, pages 4430.
Crossref
Zhenzhen Zheng, Chaoyu Wang, Chunhe Li, Qinglan Wu, Xiaojuan Chen, Huimin Chen, Huizhao Liao, Jinru Zhu, Junyan Lin, Xudong Ou, Zhihong Zou, Jinhua Liang & Riken Chen. (2022) Meta-Analysis of Relationship of Sleep Quality and Duration With Risk of Diabetic Retinopathy. Frontiers in Endocrinology 13.
Crossref
Khara Lucius. (2022) Melatonin Beyond Sleep, Part I: An Overview. Integrative and Complementary Therapies 28:3, pages 138-145.
Crossref
Samraa H. Abdel-Kawi & Khalid S. Hashem. (2022) Administration of Melatonin in Diabetic Retinopathy Is Effective and Improves the Efficacy of Mesenchymal Stem Cell Treatment. Stem Cells International 2022, pages 1-17.
Crossref
Somsubhra Dutta, Sambuddha Ghosh & Srijit Ghosh. (2020) Association of sleep disturbance with diabetic retinopathy. European Journal of Ophthalmology 32:1, pages 468-474.
Crossref
Klausen Oliveira-Abreu, José Cipolla-Neto & Jose Henrique Leal-Cardoso. (2021) Effects of Melatonin on Diabetic Neuropathy and Retinopathy. International Journal of Molecular Sciences 23:1, pages 100.
Crossref
Prakash Adhikari, Asik Pradhan, Andrew J. Zele & Beatrix Feigl. (2021) Supplemental light exposure improves sleep architecture in people with type 2 diabetes. Acta Diabetologica 58:9, pages 1201-1208.
Crossref
Victoria Eugenia Lledó, Hanan Awad Alkozi, Juan Sánchez-Naves, Miguel Angel Fernandez-Torres & Ana Guzman-Aranguez. (2021) Modulation of aqueous humor melatonin levels by yellow-filter and its protective effect on lens. Journal of Photochemistry and Photobiology B: Biology 221, pages 112248.
Crossref
Supamas Sirisreetreerux, Tharikarn Sujirakul, Hataikarn Nimitphong, Sittichai Pinyopodjanard, Sunee Saetung, La-or Chailurkit, Naricha Chirakalwasan, Ben S. Gerber & Sirimon Reutrakul. (2020) Sleep variability, 6-sulfatoxymelatonin, and diabetic retinopathy. Sleep and Breathing 25:2, pages 1069-1074.
Crossref
Yuanyuan Tu, E Song, Zhenzhen Wang, Na Ji, Linling Zhu, Kun Wang, Haotian Sun, Yuting Zhang, Qiujian Zhu, Xiaojuan Liu & Manhui Zhu. (2021) Melatonin attenuates oxidative stress and inflammation of Müller cells in diabetic retinopathy via activating the Sirt1 pathway. Biomedicine & Pharmacotherapy 137, pages 111274.
Crossref
Kenichi Tanaka, Yosuke Okada, Hajime Maiko, Hiroko Mori & Yoshiya Tanaka. (2020) Associations between urinary 6‐sulfatoxymelatonin excretion and diabetic vascular complications or arteriosclerosis in patients with type 2 diabetes. Journal of Diabetes Investigation 12:4, pages 601-609.
Crossref
Mengyang Yan, Haochen Wang, Yu Gu, Xin Li, Luyang Tao & Peirong Lu. (2021) Melatonin exerts protective effects on diabetic retinopathy via inhibition of Wnt/β-catenin pathway as revealed by quantitative proteomics. Experimental Eye Research 205, pages 108521.
Crossref
Jakob Grauslund, Lonny Stokholm, Anne S. Thykjær, Sören Möller, Caroline S. Laugesen, Jens Andresen, Toke Bek, Morten la Cour, Steffen Heegaard, Kurt Højlund, Ryo Kawasaki, Javad Hajari, Kirsten O. Kyvik, Katja C. Schielke, Katrine H. Rubin & Malin L. Rasmussen. (2021) Inverse Cross-sectional and Longitudinal Relationships between Diabetic Retinopathy and Obstructive Sleep Apnea in Type 2 Diabetes. Ophthalmology Science 1:1, pages 100011.
Crossref
Alejandro Martínez-Águila, Alba Martín-Gil, Carlos Carpena-Torres, Cristina Pastrana & Gonzalo Carracedo. (2021) Influence of Circadian Rhythm in the Eye: Significance of Melatonin in Glaucoma. Biomolecules 11:3, pages 340.
Crossref
Wen-Cui Wan, Yang Long, Wei-Wei Wan, Hong-Zhuo Liu, Hao-Hao Zhang & Wei Zhu. (2021) Plasma melatonin levels in patients with diabetic retinopathy secondary to type 2 diabetes. World Journal of Diabetes 12:2, pages 138-148.
Crossref
Daniel P. Cardinali & Daniel E. Vigo. 2021. Psychiatry and Neuroscience Update. Psychiatry and Neuroscience Update 279 302 .
Mohammad Hossein Pourhanifeh, Azam Hosseinzadeh, Ehsan Dehdashtian, Karim Hemati & Saeed Mehrzadi. (2020) Melatonin: new insights on its therapeutic properties in diabetic complications. Diabetology & Metabolic Syndrome 12:1.
Crossref
Anna van der Veen, Isidor Minović, Martijn van Faassen, Antόnio W. Gomes-Neto, Stefan P. Berger, Stephan J. L. Bakker & Ido P. Kema. (2020) Urinary Excretion of 6-Sulfatoxymelatonin, the Main Metabolite of Melatonin, and Mortality in Stable Outpatient Renal Transplant Recipients. Journal of Clinical Medicine 9:2, pages 525.
Crossref
Sirimon Reutrakul, Stephanie J. Crowley, Jason C. Park, Felix Y. Chau, Medha Priyadarshini, Erin C. Hanlon, Kirstie K. Danielson, Ben S. Gerber, Tracy Baynard, Jade J. Yeh & J. Jason McAnany. (2020) Relationship between Intrinsically Photosensitive Ganglion Cell Function and Circadian Regulation in Diabetic Retinopathy. Scientific Reports 10:1.
Crossref
Ieva Kalere, Ilze Konrāde, Anna Proskurina, Sabīne Upmale, Tatjana Zaķe, Normunds Limba, Gita Krieviņa, Aivars Lejnieks & Pēteris Tretjakovs. (2019) Melatonin Concentrations and Sleep Quality in Patients with Type 2 Diabetes and Obesity. Proceedings of the Latvian Academy of Sciences. Section B. Natural, Exact, and Applied Sciences. 73:2, pages 152-157.
Crossref
Sunila Dumpala, Andrew J. Zele & Beatrix Feigl. (2019) Outer Retinal Structure and Function Deficits Contribute to Circadian Disruption in Patients With Type 2 Diabetes. Investigative Opthalmology & Visual Science 60:6, pages 1870.
Crossref
Shakoor Ba-Ali, Adam Elias Brøndsted, Henrik Ullits Andersen, Birgit Sander, Poul Jørgen Jennum & Henrik Lund-Andersen. (2019) Assessment of diurnal melatonin, cortisol, activity, and sleep−wake cycle in patients with and without diabetic retinopathy. Sleep Medicine 54, pages 35-42.
Crossref
Fariba Raygan, Vahidreza Ostadmohammadi, Fereshteh Bahmani, Russel J. Reiter & Zatollah Asemi. (2019) Melatonin administration lowers biomarkers of oxidative stress and cardio-metabolic risk in type 2 diabetic patients with coronary heart disease: A randomized, double-blind, placebo-controlled trial. Clinical Nutrition 38:1, pages 191-196.
Crossref
Susan Kohl Malone, Maria A. Mendoza & Freda Patterson. 2019. Sleep and Health. Sleep and Health 227 240 .
S. Strohmaier, E. E. Devore, Y. Zhang & E. S. Schernhammer. (2018) A Review of Data of Findings on Night Shift Work and the Development of DM and CVD Events: a Synthesis of the Proposed Molecular Mechanisms. Current Diabetes Reports 18:12.
Crossref
Josephine B. Hebsgaard, Charles Pyke, Emre Yildirim, Lotte B. Knudsen, Steffen Heegaard & Peter H. Kvist. (2018) Glucagon-like peptide-1 receptor expression in the human eye. Diabetes, Obesity and Metabolism 20:9, pages 2304-2308.
Crossref
Nicholas Y. Q. Tan, Merwyn Chew, Yih-Chung Tham, Quang Duc Nguyen, Masayuki Yasuda, Ching-Yu Cheng, Tien Yin Wong & Charumathi Sabanayagam. (2018) Associations between sleep duration, sleep quality and diabetic retinopathy. PLOS ONE 13:5, pages e0196399.
Crossref
Daniel P. Cardinali & Daniel E. Vigo. (2017) Melatonin, mitochondria, and the metabolic syndrome. Cellular and Molecular Life Sciences 74:21, pages 3941-3954.
Crossref
Almudena Crooke, Fernando Huete-Toral, Basilio Colligris & Jesús Pintor. (2017) The role and therapeutic potential of melatonin in age-related ocular diseases. Journal of Pineal Research 63:2, pages e12430.
Crossref
Andrew C. Forrestel, Susanne U. Miedlich, Michael Yurcheshen, Steven D. Wittlin & Michael T. Sellix. (2016) Chronomedicine and type 2 diabetes: shining some light on melatonin. Diabetologia 60:5, pages 808-822.
Crossref
Lars Peter Holst Andersen, Ismail Gögenur, Jacob Rosenberg & Russel J. Reiter. (2016) Pharmacokinetics of Melatonin: The Missing Link in Clinical Efficacy?. Clinical Pharmacokinetics 55:9, pages 1027-1030.
Crossref
Mayuko Kadono, Naoko Nakanishi, Masahiro Yamazaki, Goji Hasegawa, Naoto Nakamura & Michiaki Fukui. (2016) Various patterns of disrupted daily rest-activity rhythmicity associated with diabetes. Journal of Sleep Research 25:4, pages 426-437.
Crossref
Cody A Ramin, Jennifer Massa, Lani R Wegrzyn, Susan B Brown, Jeffrey Pierre-Paul, Elizabeth E Devore, Susan E Hankinson & Eva S Schernhammer. (2015) The association of body size in early to mid-life with adult urinary 6-sulfatoxymelatonin levels among night shift health care workers. BMC Public Health 15:1.
Crossref
Ugur Unluturk & Tomris Erbas. 2015. Tryptophan Metabolism: Implications for Biological Processes, Health and Disease. Tryptophan Metabolism: Implications for Biological Processes, Health and Disease 147 171 .
Moe H. Aung, Han na Park, Moon K. Han, Tracy S. Obertone, Jane Abey, Fazila Aseem, Peter M. Thule, P. Michael Iuvone & Machelle T. Pardue. (2014) Dopamine Deficiency Contributes to Early Visual Dysfunction in a Rodent Model of Type 1 Diabetes. The Journal of Neuroscience 34:3, pages 726-736.
Crossref
Frederic Nduhirabandi & Amanda Lochner. 2014. Melatonin and Melatonergic Drugs in Clinical Practice. Melatonin and Melatonergic Drugs in Clinical Practice 71 95 .
Vladimir Iosifovich Konenkov, Vadim Valerievich Klimontov, Svetlana Viktorovna Michurina, M A Prudnikova & I Ju Ishenko. (2013) Melatonin and diabetes: from pathophysiology to the treatment perspectives. Diabetes mellitus 16:2, pages 11-16.
Crossref
Simone Mäntele, Daniella T. Otway, Benita Middleton, Silvia Bretschneider, John Wright, M. Denise Robertson, Debra J. Skene & Jonathan D. Johnston. (2012) Daily Rhythms of Plasma Melatonin, but Not Plasma Leptin or Leptin mRNA, Vary between Lean, Obese and Type 2 Diabetic Men. PLoS ONE 7:5, pages e37123.
Crossref